Revision of quality indicators for cervical cancer and trend analysis of existing indicators in Japan
The QIs for cervical cancer in Japan have been revised based on 2022 evidence. The existing and new indicators should be continually evaluated to correspond to the latest knowledge. This will facilitate the standardization and promotion of bottom-up improvements in cervical cancer care.
Authors
- Kiyoshi Yoshino (ORCID: https://orcid.org/0000-0002-5732-5215)
- Yasuyuki Hirashima (ORCID: https://orcid.org/0000-0003-0269-9313)
- Yuichi Ichinose (ORCID: https://orcid.org/0000-0002-2474-785X)
- Manabu Seino (ORCID: https://orcid.org/0000-0002-7511-5190)
- Wataru Yamagami (ORCID: https://orcid.org/0000-0003-3925-6057)
- Tsukasa Baba (ORCID: https://orcid.org/0000-0003-0066-3747)
- Ryoko Rikitake (ORCID: https://orcid.org/0000-0002-0232-8283)
- Kazuhiro Takehara (ORCID: https://orcid.org/0000-0001-8808-3338)
- Tamaki Kakuwa (ORCID: https://orcid.org/0000-0002-6238-2003)
- Hideki Tokunaga (ORCID: https://orcid.org/0000-0002-1622-3810)
- Takahiro Higashi (ORCID: https://orcid.org/0000-0002-9933-2106)
- Satoru Nagase (ORCID: https://orcid.org/0000-0001-5212-1128)
- Masanori Kaneuchi (ORCID: https://orcid.org/0000-0002-2479-1164)
- Hitoshi Niikura (ORCID: https://orcid.org/0000-0002-2769-3922)
- Mikio Mikami (ORCID: https://orcid.org/0000-0002-7496-3518)
- Toshinari Muramatsu
- Akira Kawata
Institutions
- Yamagata University (JP)
- Tokai University (JP)
- Iwate Medical University (JP)
- University of Occupational and Environmental Health Japan (JP)
- Keio University (JP)
- Shizuoka Cancer Center (JP)
- Tokai University Hachioji Hospital (JP)
- Otaru Municipal Hospital (JP)
- Sendai Medical Center (JP)
- Shikoku Cancer Center (JP)
- The University of Tokyo (JP)
- Tohoku Medical and Pharmaceutical University (JP)
Publication Details
- Journal
- Journal of Gynecologic Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.3802/jgo.2025.36.e78
- Citations
- 1
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06
Funders
- AstraZeneca
- Sanofi
- Daiichi-Sankyo
- Chugai Pharmaceutical